Zytologische Kontrollen der Cervix uteri

• Literatur

• 1 DGGG. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e. V. Leitlinien, Empfehlungen, Stellungnahmen Stand August 2010. 1 Allgemeine Gynäkologie und gynäkologische Onkologie; 1.4 Gynäkologische Infektiologie; 1.4.4 Prävention, Diagnostik und Therapie der HPV-Infektion und präinvasiver Läsionen des weiblichen Genitale. http://www.dggg.de/fileadmin/public_docs/Leitlinien/1-4-4-hpv-2010.pdf
• 2 CPC A. Empfehlungen der AGCPC zur Kolposkopie, Diagnostik und Therapie bei Erkrankungen des unteren Genitaltraktes der Frau. 2009 http://www.ag-cpc.de/media/Empfehlungen%20AGCPC%209-2009.pdf
• 3 Kjaer S, Hogdall E, Frederiksen K et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 2006; 66: 10630-10636
• 4 Petry KU, Meijer CJ, Hoyer H et al. Aaaaaa. Int J Cancer; 2010: 1095-1101 2006/04/06 ed
• 5 Ferris DG, Spitzer M, Werner C et al. Colposcopy quality control for clinical trials: the positive effects from brief, intensive educational intervention. J Lower Genital Tract Disease 2002; 6: 11-16
• 6 Khleif SN, DeGregori J, Yee CL et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci 1996; 93: 4350-4354
• 7 Klaes R, Friedrich T, Spitkovsky D et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-284
• 8 Mittal K, Mesia A, Demopoulos RI. MIB-1 expression is useful in distinguishing dysplasia from atrophy in elderly women. Int J Gyn Pathol 1999; 18: 122-124
• 9 Kruse AJ, Baak JP, Helliesen T et al. Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 1501-1507
• 10 Griesser H, Sander H, Hilfrich R et al. Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia. Analyt Quant Cytol Histol 2004; 26: 241-245
• 11 Melsheimer P, Kaul S, Dobeck S et al. Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA. Acta Cytol 2003; 47: 124-128
• 12 Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gyn Pathol 1993; 12: 186-192
• 13 Kyrgiou M, Koliopoulos G, Martin-Hirsch P et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489-498
• 14 Nohr B, Tabor A, Frederiksen K et al. Loop electrosurgical excision of the cervix and the subsequent risk of preterm delivery. Acta Obstet Gynaecol Scandinavica 2007; 86: 596-603
• 15 Jakobsson M, Gissler M, Sainio S et al. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2007; 109: 309-313
• 16 Bevis KS, Biggio JR. Cervical conization and the risk of preterm delivery. Am J Obstet Gynecol 2011; 1: 1-1
• 17 Gallwas J, Ditsch N, Hillemanns P et al. The significance of HPV in the follow-up period after treatment for CIN. Eur J Gynecol Oncol 2010; 31: 27-30
• 18 Reich O, Lahousen M, Pickel H et al. Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife conization with involved margins. Obstet Gynecol 2002; 99: 193-196
• 19 Seidl S. Praxis der Kolposkopie. München: Hans Marseille Verlag GmbH; 1988: 324-330
• 20 Lellé R, Küppers V. Kolposkopie in der Praxis. Heidelberg: Springer Medizin Verlag; 2008: 75-83
• 21 Gonçalves CV, Duarte G, Dias da Costa JS et al. Diagnosis and treatment of cervical cancer during pregnancy. Sao Paulo Medical Journal 2009; 127: 359-365
• 22 Method MW, Brost BC. Management of cervical cancer in pregnancy. Semin Surg Oncol 1999; 16: 251-260
• 23 Mir O, Berveiller P, Ropert S et al. Use of platinium derivatives during pregnancy. Cancer 2008; 113: 3069-3074